+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Portable Oxygen Concentrator Market - Forecasts from 2025 to 2030

  • PDF Icon

    Report

  • 141 Pages
  • December 2024
  • Region: Global
  • Knowledge Sourcing Intelligence LLP
  • ID: 5397920
The portable oxygen concentrator market is estimated to attain US$4.869 billion by 2030, growing at a CAGR of 11.23%, from US$2.860 billion in 2025.

A portable oxygen concentrator is a device which features a small, lightweight, and silent design and offers patients a continuous supply of oxygen. Hence, they offer applicability across multiple sectors, which majorly includes utilization in homecare settings, ambulances, and aero-ambulances. The portable oxygen concentrator ensures a higher oxygen output and it also helps in increasing the survival rate of the critical patients.

The demand for portable oxygen concentrators in the global market is expected to witness a significant increase fuelled with the increasing older population across the world as they offers multiple benefits to the older population such as increasing the body's ability to inhale pure oxygen. With the increasing age of individuals, the risk of various types of respiratory or pulmonary diseases like chronic obstructive pulmonary disease (COPD), asthma, pneumonia, and other type of lung diseases increase drastically.

The World Bank, in its global population report, stated that in 2024, the total population aged 65 years and above was recorded at 804.475 million. This marked a major growth from 2021, when the total population aged 65 and above was recorded at 754.681 million, and about 778.122 million in 2022.

Portable Oxygen Concentrator Market Drivers

Growing global cases of respiratory diseases is propelling the market expansion

The increasing global cases of pulmonary or respiratory diseases are among the key factors propelling the growth of the global portable oxygen concentrator market during the estimated timeline. The global cases of various types of respiratory and lung diseases like COPD, emphysema, and chronic bronchitis witnessed major growth across the globe. The cases of respiratory diseases witnessed a growth majorly caused by various factors like pollution, age, and lifestyle of the individuals.

The American Lung Association in its report stated that in the USA, about 11.7 million adults are affected by COPD or chronic obstructive pulmonary disease. Similarly, the Centers for Disease Control and Prevention of the USA stated that in the nation, about 4.3% of the total population of the nation, in 2023, were diagnosed with COPD, emphysema, or chronic bronchitis. The agency further stated that in the nation, chronic lower respiratory disease, which includes asthma caused about 147,382 deaths, which is equal to about 44.2 deaths per 100,000 population of the nation. The agency stated that emphysema and bronchitis diseases in 2023 caused about 7,905 and 358 deaths respectively, whereas the other chronic lower respiratory diseases which excludes asthma caused 135,517 deaths. In the nation, asthma caused about 3,602 deaths, which is equivalent to 1.1 deaths per 100,000 population.

Similarly, Statistics Canada, in its report stated that the cases of deaths caused by various types of respiratory diseases also witnessed a constant growth. The agency stated that in 2021, about 311,640 deaths in the nation were caused by respiratory disease, which increased to 334,081 in 2022. Likewise, the same source also specified that the deaths caused by chronic lower respiratory diseases increased in the nation from 11,018 deaths in 2021 to 12,462 deaths in 2022. In 2023, the total number of deaths caused by chronic lower respiratory diseases was recorded at 12,994.

The cases of respiratory diseases in India also witnessed significant growth during the past few years. The major factor boosting the cases of pulmonary and respiratory diseases in the Indian market is the increasing pollution and rising consumption of tobacco. The National Institute of Health of the Indian Government in its report stated that air pollution in the nation caused about 25.6% of the total cases of chronic obstructive pulmonary disease or COPD, and tobacco is responsible for about 16.5% of the cases. The Indian Journal of Public Health in its report stated that in India, the total cases of COPD were estimated at 37.8 million. which is about 17.8% of the total global cases. The journal also stated that the cases of COPD in the nation contribute to about 27.3% of the global deaths, caused by COPD.

Furthermore, the Scottish Public Health Observatory under its Public Health Information for Scotland platform stated that in Scotland, the cases of COPD witnessed a major growth from 2018, to 2023. The agency further stated that in the nation, the total deaths caused by COPD in Scotland was recorded at 2.2% for males, whereas the death rate caused by COPD for women was recorded at 2.4%.

Portable Oxygen Concentrator Market Geographical Outlook:

The North America is expected to dominate the market in the coming years

Portable oxygen concentrators form an integral part of long-term oxygen therapy as they reduce the gap between oxygen solutions availability and their usage for patients suffering from chronic obstructive pulmonary disease or lung cancer. Tackling such disease has become a major concern in the United States with various investments and initiatives being undertaken to bolster the development of required solutions.

According to the Lung Cancer Research Foundation, nearly 654,620 Americans have been diagnosed with lung cancer at some point in their lives, and the annual death count reaches up to 125,070 annually. Likewise, according to the 'State of Lung Cancer Report 2023' issued by the American Lung Association, nearly 238,000 people were diagnosed with lung cancer in 2023 which represented an increase of 1,000 new cases in comparison to 2022.

Moreover, old age people are more prone to respiratory and lung disease and with the constant growth in the geriatric population of the United States, the probability of people getting diagnosed with some form of respiratory disease is also expected to grow. According to the Population Reference Bureau, by 2050 population aged 65 years and above will reach up to 82 million thereby signifying a remarkable growth of 47% over the population recorded in 2022. Hence the same source further specified that the percentage share of old age people will increase from 17% to 23% in the given period.

However, the ongoing developments in lung cancer treatment over the years have reduced the prevalence rate thereby providing a major scope for the usage of portable oxygen concentrators. As per the American Lung Cancer Association, the survival rate of Americans has improved by 26% over the past five years, with the federal government working on opportunities to increase cancer screening and increase access to required oxygen solutions for patients.

Moreover, major players operating in portable oxygen concentrators have established their base in the US market as they aim to optimize the growing opportunity. For instance, as per the 2023 annual report of Inogen Inc. of the total company revenue of US$315.600 million, the United States contributed US$226.3 million thereby constituting nearly 70% of the total revenue.

Furthermore, the company is also investing in new product launches with the recent development being made in October 2024, where the company introduced the 'Rove 4' portable oxygen concentrator that is ideal for home care settings in the US market, Additionally, the company, in August 2023, showcased' Rove 6' portable oxygen concentrator in the US. Hence, such ongoing developments followed by constant efforts being made to reduce the mortality rate of lung cancer patients have paved the way for the future market expansion of long-term oxygen therapy solutions such as portable oxygen concentrators.

Reasons for buying this report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape up future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data & forecasts from 2022 to 2029
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

The Portable Oxygen Concentrator Market is analyzed into the following segments:

By Product

  • Continuous Flow Portable Oxygen concentrator
  • Pulse Flow Portable Oxygen Concentrator

By End-User

  • Homecare Setting
  • Air Ambulance
  • Others

By Geography

  • North America
  • South America
  • Europe
  • Middle East and Africa
  • Asia-Pacific

Table of Contents

1. Introduction
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base and Forecast Years Timeline
1.8. Key Benefits for Stakeholders
2. Research Methodology
2.1. Research Design
2.2. Research Process
2.3. Data Validation
3. Executive Summary
3.1. Key Findings
3.2. Analyst View
4. Market Dynamics
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter's Five Forces Analysis
4.3.1. Bargaining Power of Supplier
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
5. Portable Oxygen Concentrator Market By Product
5.1. Introduction
5.2. Continuous Flow Portable Oxygen Concentrator
5.3. Pulse Flow Portable Oxygen Concentrator
6. Portable Oxygen Concentrator Market By End-User
6.1. Introduction
6.2. Homecare Setting
6.3. Air Ambulance
6.4. Others
7. Portable Oxygen Concentrator Market By Geography
7.1. Introduction
7.2. North America
7.2.1. By Product
7.2.2. By End-User
7.2.3. By Country
7.2.3.1. United States
7.2.3.2. Canada
7.2.3.3. Mexico
7.3. South America
7.3.1. By Product
7.3.2. By End-User
7.3.3. By Country
7.3.3.1. Brazil
7.3.3.2. Argentina
7.3.3.3. Others
7.4. Europe
7.4.1. By Product
7.4.2. By End-User
7.4.3. By Country
7.4.3.1. United Kingdom
7.4.3.2. Germany
7.4.3.3. France
7.4.3.4. Italy
7.4.3.5. Spain
7.4.3.6. Others
7.5. Middle East and Africa
7.5.1. By Product
7.5.2. By End-User
7.5.3. By Country
7.5.3.1. Saudi Arabia
7.5.3.2. UAE
7.5.3.3. Others
7.6. Asia Pacific
7.6.1. By Product
7.6.2. By End-User
7.6.3. By Country
7.6.3.1. China
7.6.3.2. Japan
7.6.3.3. South Korea
7.6.3.4. India
7.6.3.5. Indonesia
7.6.3.6. Thailand
7.6.3.7. Taiwan
7.6.3.8. Others
8. Competitive Environment and Analysis
8.1. Major Players and Strategy Analysis
8.2. Emerging Players and Market Lucrativeness
8.3. Mergers, Acquisitions, Agreements, and Collaborations
8.4. Competitive Dashboard
9. Company Profiles
9.1. Precision Medical Inc.
9.2. Nidek Medical Products Inc.
9.3. Philips Healthcare
9.4. Drive DeVilbiss international
9.5. Invacare Corporation
9.6. Chart Industries
9.7. Inogen Inc
9.8. Summit Oxygen international
9.9. Nareena Lifesciences Private Limited
9.10. Anand Medicaids
9.11. Hindustan Engineers
9.12. Global Medical Devices
9.13. EVOX, India

Companies Mentioned

  • Precision Medical Inc.
  • Nidek Medical Products Inc.
  • Philips Healthcare
  • Drive DeVilbiss international
  • Invacare Corporation
  • Chart Industries
  • Inogen Inc
  • Summit Oxygen international
  • Nareena Lifesciences Private Limited
  • Anand Medicaids
  • Hindustan Engineers
  • Global Medical Devices
  • EVOX, India

Methodology

Loading
LOADING...

Table Information